XML 36 R21.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Earnings (Loss) Per Common Share | 12 Months Ended
--- | ---
Dec. 31, 2021
Earnings Per Share [Abstract] |
Earnings (Loss) Per Common Share | Earnings (Loss) Per Common Share The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):
| For the Year Ended December 31,
| 2021 |  | 2020 |  | 2019
Loss from continuing operations | $ | (30,284) |  |  | $ | (328,172) |  |  | $ | (307,193) |
Income (loss) from discontinued operations, net of tax | (7,317) |  |  | (6,074) |  |  | 1,613 |
Net loss | (37,601) |  |  | (334,246) |  |  | (305,580) |
Less: |  |  |  |  |
Net loss attributable to non-controlling interests | — |  |  | — |  |  | (3,609) |
Net loss available for common shareholders - basic and diluted | $ | (37,601) |  |  | $ | (334,246) |  |  | $ | (301,971) |
Weighted-average common shares outstanding - basic and diluted | 86,067 |  |  | 84,928 |  |  | 82,364 |
Income (loss) per common share |  |  |  |  |
Basic and diluted |  |  |  |  |
Continuing operations | $ | (0.35) |  |  | $ | (3.86) |  |  | $ | (3.73) |
Discontinued operations | (0.09) |  |  | (0.08) |  |  | 0.02 |
Non-controlling interests | — |  |  | — |  |  | 0.04 |
Basic and diluted income (loss) per share attributable to common shareholders of Evolent Health, Inc. | $ | (0.44) |  |  | $ | (3.94) |  |  | $ | (3.67) |
Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:
| For the Year Ended December 31,
| 2021 |  | 2020 |  | 2019
Exchangeable Class B common stock | — |  |  | — |  |  | 1,399 |
Restricted stock units ("RSUs"), performance-based RSUs and leveraged stock units ("LSUs") | 1,807 |  |  | 797 |  |  | 813 |
Stock options | 2,036 |  |  | 1,141 |  |  | 1,324 |
Convertible senior notes | 12,602 |  |  | 11,206 |  |  | 10,361 |
Total | 16,445 |  |  | 13,144 |  |  | 13,897 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration